Standout Papers

Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors 2023 2026 202491
  1. Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors (2023)
    Seyed Arad Moghadasi, Emmanuel Heilmann et al. Science Advances

Immediate Impact

3 from Science/Nature 26 standout
Sub-graph 1 of 12

Citing Papers

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
2024 Standout
3 intermediate papers

Works of Sofia N. Moraes being referenced

Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
2023 Standout
Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 M pro /3CL pro in Living Cells
2022

Author Peers

Author Last Decade Papers Cites
Sofia N. Moraes 51 96 32 117 63 12 281
Mohd Ishtiaq Anasir 45 127 15 80 39 17 254
Itai Bloch 29 170 23 37 64 23 308
Megan C. Mears 48 99 9 241 49 10 334
San Sui Lim 49 80 31 44 106 14 277
Haruaki Nobori 60 61 11 133 23 18 257
Abhishek Vartak 58 186 22 83 135 10 335
Rafiq Nabi 88 63 31 115 76 13 267
Maitreyi Shivkumar 138 77 21 65 84 15 320
Ramona Businger 55 59 26 78 98 17 244
Shilei Zhang 67 105 15 115 119 14 302

All Works

Loading papers...

Rankless by CCL
2026